Net Income Summary of Changjiang Pharmaceutical Group Co., Ltd.

Changjiang Pharmaceutical Group Co., Ltd.'s latest annual net income in 2023 was -605.65 Million CNY , down -2502.35% from previous year.
Changjiang Pharmaceutical Group Co., Ltd.'s latest quarterly net income in 2024 Q2 was -105.06 Million CNY , down -121.17% from previous quarter.
Changjiang Pharmaceutical Group Co., Ltd. reported an annual net income of -23.27 Million CNY in 2022, down -147.4% from previous year.
Changjiang Pharmaceutical Group Co., Ltd. reported an annual net income of 49.1 Million CNY in 2021, up 93.94% from previous year.
Changjiang Pharmaceutical Group Co., Ltd. reported a quarterly net income of -47.5 Million CNY for 2024 Q1, up 90.3% from previous quarter.
Changjiang Pharmaceutical Group Co., Ltd. reported a quarterly net income of -105.06 Million CNY for 2024 Q2, down -121.17% from previous quarter.

Annual Net Income Chart of Changjiang Pharmaceutical Group Co., Ltd. (2023 - 2009)

Historical Annual Net Income of Changjiang Pharmaceutical Group Co., Ltd. (2023 - 2009)

Year	Net Income	Net Income Growth
2023	-605.65 Million CNY	-2502.35%
2022	-23.27 Million CNY	-147.4%
2021	49.1 Million CNY	93.94%
2020	25.31 Million CNY	103.78%
2019	-669.69 Million CNY	-756.64%
2018	101.98 Million CNY	46.29%
2017	69.71 Million CNY	1551.62%
2016	4.22 Million CNY	-16.05%
2015	5.02 Million CNY	-82.49%
2014	28.71 Million CNY	-17.85%
2013	34.95 Million CNY	-1.46%
2012	35.47 Million CNY	-4.46%
2011	37.13 Million CNY	20.53%
2010	30.8 Million CNY	73.37%
2009	17.77 Million CNY	0.0%

Year	Net Income	Net Income Growth
2024 Q3	-28.39 Million CNY	72.97%
2024 Q1	-47.5 Million CNY	90.3%
2024 Q2	-105.06 Million CNY	-121.17%
2023 Q1	-22.95 Million CNY	54.72%
2023 FY	-605.65 Million CNY	-2502.35%
2023 Q4	-489.8 Million CNY	-434.5%
2023 Q3	-91.63 Million CNY	-7190.63%
2023 Q2	-1.25 Million CNY	94.53%
2022 Q3	67.7 Million CNY	223.27%
2022 FY	-23.27 Million CNY	-147.4%
2022 Q4	-50.69 Million CNY	-174.89%
2022 Q2	-54.92 Million CNY	-475.0%
2022 Q1	14.64 Million CNY	130.77%
2021 Q2	24.58 Million CNY	-58.61%
2021 Q4	-47.59 Million CNY	-474.61%
2021 FY	49.1 Million CNY	93.94%
2021 Q3	12.7 Million CNY	-48.32%
2021 Q1	59.4 Million CNY	142.93%
2020 Q1	-5.04 Million CNY	99.28%
2020 FY	25.31 Million CNY	103.78%
2020 Q4	24.45 Million CNY	197.32%
2020 Q2	-2.31 Million CNY	54.23%
2020 Q3	8.22 Million CNY	455.94%
2019 Q3	-18.45 Million CNY	-188.84%
2019 FY	-669.69 Million CNY	-756.64%
2019 Q1	24.97 Million CNY	593.65%
2019 Q2	20.77 Million CNY	-16.81%
2019 Q4	-696.99 Million CNY	-3675.84%
2018 Q1	12.41 Million CNY	-22.95%
2018 FY	101.98 Million CNY	46.29%
2018 Q4	-5.05 Million CNY	-112.48%
2018 Q3	40.53 Million CNY	-25.07%
2018 Q2	54.09 Million CNY	335.72%
2017 Q4	16.11 Million CNY	-22.45%
2017 FY	69.71 Million CNY	1551.62%
2017 Q3	20.77 Million CNY	-32.31%
2017 Q2	30.69 Million CNY	1343.7%
2017 Q1	2.12 Million CNY	1102.31%
2016 Q4	-212.14 Thousand CNY	-109.82%
2016 FY	4.22 Million CNY	-16.05%
2016 Q3	2.15 Million CNY	127.38%
2016 Q2	949.91 Thousand CNY	-28.22%
2016 Q1	1.32 Million CNY	-33.61%
2015 FY	5.02 Million CNY	-82.49%
2015 Q4	1.99 Million CNY	137.32%
2015 Q3	-5.34 Million CNY	-195.74%
2015 Q2	5.57 Million CNY	99.45%
2015 Q1	2.79 Million CNY	-66.59%
2014 Q2	10.3 Million CNY	92.34%
2014 Q1	5.35 Million CNY	-63.04%
2014 FY	28.71 Million CNY	-17.85%
2014 Q4	8.37 Million CNY	78.97%
2014 Q3	4.67 Million CNY	-54.62%
2013 FY	34.95 Million CNY	-1.46%
2013 Q2	10.27 Million CNY	60.33%
2013 Q4	14.5 Million CNY	283.65%
2013 Q3	3.78 Million CNY	-63.19%
2013 Q1	6.4 Million CNY	0.0%
2012 FY	35.47 Million CNY	-4.46%
2011 FY	37.13 Million CNY	20.53%
2010 FY	30.8 Million CNY	73.37%
2009 FY	17.77 Million CNY	0.0%

Peer Net Income Comparison of Changjiang Pharmaceutical Group Co., Ltd.

Name	Net Income	Net Income Difference
Shenzhen Neptunus Bioengineering Co., Ltd.	-1.68 Billion CNY	64.161%
Anhui Fengyuan Pharmaceutical Co., Ltd.	159.28 Million CNY	480.231%
Dong-E-E-Jiao Co.,Ltd.	1.15 Billion CNY	152.625%
Livzon Pharmaceutical Group Inc.	1.95 Billion CNY	131.001%
Hainan Haiyao Co., Ltd.	-106.48 Million CNY	-468.749%
Tus-Pharmaceutical Group Co., Ltd.	25.24 Million CNY	2498.933%
Jilin Aodong Pharmaceutical Group Co., Ltd.	1.45 Billion CNY	141.487%
Changchun High-Tech Industries (Group) Inc.	4.53 Billion CNY	113.363%
Apeloa Pharmaceutical Co.,Ltd	1.05 Billion CNY	157.389%
PKU HealthCare Corp.,Ltd.	44.35 Million CNY	1465.419%
Chengdu Huasun Technology Group Inc., Ltd.	27.65 Million CNY	2289.679%
Dezhan Healthcare Company Limited	83.31 Million CNY	826.95%
Jinling Pharmaceutical Company Limited	99.65 Million CNY	707.765%
Jiuzhitang Co., Ltd.	297.41 Million CNY	303.642%
Huapont Life Sciences Co., Ltd.	302.12 Million CNY	300.466%
Zhejiang Jingxin Pharmaceutical Co., Ltd.	618.89 Million CNY	197.86%
Shandong Wohua Pharmaceutical Co., Ltd.	58.76 Million CNY	1130.6%
Hengkang Medical Group Co., Ltd.	30.77 Million CNY	2067.905%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.	263.27 Million CNY	330.047%
Qianjiang Yongan Pharmaceutical Co., Ltd.	-12.31 Million CNY	-4818.987%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	-783.25 Million CNY	22.675%
Jinhe Biotechnology CO., LTD.	86.45 Million CNY	800.525%
Teyi Pharmaceutical Group Co.,Ltd	253.17 Million CNY	339.222%
Kunming Longjin Pharmaceutical Co., Ltd.	-70.94 Million CNY	-753.737%
Beijing Aosaikang Pharmaceutical Co., Ltd.	-148.52 Million CNY	-307.766%
Chengdu Kanghong Pharmaceutical Group Co., Ltd	1.04 Billion CNY	157.97%
Anhui Huangshan Capsule Co., Ltd.	64.86 Million CNY	1033.736%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd	110.43 Million CNY	648.439%
Zhuhai Rundu Pharmaceutical Co., Ltd.	66.89 Million CNY	1005.33%
Huaren Pharmaceutical Co., Ltd.	188.06 Million CNY	422.048%
Tianjin Ringpu Bio-Technology Co.,Ltd.	452.94 Million CNY	233.715%
Shanxi Zhendong Pharmaceutical Co.,Ltd	-43.98 Million CNY	-1276.982%
Fuan Pharmaceutical (Group) Co., Ltd.	231.86 Million CNY	361.205%
Hybio Pharmaceutical Co., Ltd.	-513.87 Million CNY	-17.86%
Baotou Dongbao Bio-Tech Co.,Ltd	119.88 Million CNY	605.194%
Hunan Er-Kang Pharmaceutical Co., Ltd	-195.32 Million CNY	-210.079%
Zhejiang Garden Bio-chemical High-tech Co., Ltd.	192.34 Million CNY	414.872%
Fujian Cosunter Pharmaceutical Co., Ltd.	-348.58 Million CNY	-73.744%
Beijing Science Sun Pharmaceutical Co., Ltd.	102.91 Million CNY	688.482%
Zhejiang Xinguang Pharmaceutical Co., Ltd.	64.35 Million CNY	1041.091%
Hainan Poly Pharm. Co., Ltd	85.92 Million CNY	804.88%
Jiangxi Synergy Pharmaceutical Co., Ltd.	105.98 Million CNY	671.461%
Wuhan Hiteck Biological Pharma Co.,Ltd	-120.82 Million CNY	-401.274%
Shandong Xinhua Pharmaceutical Company Limited	496.51 Million CNY	221.982%
Zhejiang Tianyu Pharmaceutical Co., Ltd.	27.35 Million CNY	2313.705%
PharmaBlock Sciences (Nanjing), Inc.	197.36 Million CNY	406.876%
Jinghua Pharmaceutical Group Co., Ltd.	247.69 Million CNY	344.514%
Zhejiang Hisoar Pharmaceutical Co., Ltd.	-420.05 Million CNY	-44.184%
Betta Pharmaceuticals Co., Ltd.	348.03 Million CNY	274.022%
Tibet AIM Pharm. Inc.	15.38 Million CNY	4036.27%
Shenzhen Kangtai Biological Products Co., Ltd.	861.3 Million CNY	170.318%
Shandong Shanda Wit Science and Technology Co., Ltd.	585.26 Million CNY	203.484%
Pacific Shuanglin Bio-pharmacy Co., LTD	612.11 Million CNY	198.945%
Zhejiang AngLiKang Pharmaceutical CO.,LTD.	138.37 Million CNY	537.698%
Xiamen Kingdomway Group Company	276.71 Million CNY	318.875%
ShanXi C&Y Pharmaceutical Group Co., Ltd.	25.19 Million CNY	2503.807%
Walvax Biotechnology Co., Ltd.	419.39 Million CNY	244.413%
Sunflower Pharmaceutical Group Co.,Ltd	1.11 Billion CNY	154.118%
Harbin Gloria Pharmaceuticals Co., Ltd	120.33 Million CNY	603.309%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.	2.85 Billion CNY	121.229%
Hunan Hansen Pharmaceutical Co., Ltd.	205.01 Million CNY	395.419%
Changzhou Qianhong Biopharma CO.,LTD	181.86 Million CNY	433.031%
Shenzhen Weiguang Biological Products Co., Ltd.	218.65 Million CNY	376.995%
Honz Pharmaceutical Co., Ltd.	11.52 Million CNY	5352.91%
Northeast Pharmaceutical Group Co., Ltd.	358.45 Million CNY	268.961%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	43.93 Million CNY	1478.562%
Guizhou Xinbang Pharmaceutical Co., Ltd.	287.23 Million CNY	310.858%
Tianjin Lisheng Pharmaceutical Co.,Ltd.	361.82 Million CNY	267.387%
Zhejiang Yatai Pharmaceutical Co., Ltd.	-11.87 Million CNY	-4999.394%
Zhejiang NHU Company Ltd.	2.7 Billion CNY	122.396%
ApicHope Pharmaceutical Co., Ltd	184.61 Million CNY	428.066%
Shanghai Kaibao Pharmaceutical CO.,Ltd	327.87 Million CNY	284.723%
Beijing SL Pharmaceutical Co., Ltd.	416.69 Million CNY	245.348%
Yunnan Baiyao Group Co.,Ltd	4.09 Billion CNY	114.794%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD	61.64 Million CNY	1082.443%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.	161.53 Million CNY	474.936%
Guangdong Lifestrong Pharmacy Co., Ltd.	33.5 Million CNY	1907.829%
Huadong Medicine Co., Ltd	2.83 Billion CNY	121.334%
Jiangsu Nhwa Pharmaceutical Co., LTD	1.03 Billion CNY	158.409%
Harbin Medisan Pharmaceutical Co., Ltd.	73.66 Million CNY	922.194%
LanZhou Foci Pharmaceutical Co.,Ltd.	67.18 Million CNY	1001.408%
Tianjin Chase Sun Pharmaceutical Co.,Ltd	506.63 Million CNY	219.545%
Beijing Beilu Pharmaceutical Co., Ltd	-71.75 Million CNY	-744.032%
Nanjing Hicin Pharmaceutical Co., Ltd.	36.31 Million CNY	1767.752%
Renhe Pharmacy Co., Ltd.	567.25 Million CNY	206.769%
Chongqing Pharscin Pharmaceutical Co., Ltd.	32.69 Million CNY	1952.199%
Zhejiang Xianju Pharmaceutical Co.,Ltd.	563.08 Million CNY	207.56%
Luoxin Pharmaceuticals Group Stock Co., Ltd.	-661.13 Million CNY	8.392%
Guizhou Bailing Group Pharmaceutical Co., Ltd.	-414.51 Million CNY	-46.113%

Global Stocks Search

Changjiang Pharmaceutical Group Co., Ltd. (300391.SZ)

Net Income Summary of Changjiang Pharmaceutical Group Co., Ltd.

Annual Net Income Chart of Changjiang Pharmaceutical Group Co., Ltd. (2023 - 2009)

Historical Annual Net Income of Changjiang Pharmaceutical Group Co., Ltd. (2023 - 2009)

Peer Net Income Comparison of Changjiang Pharmaceutical Group Co., Ltd.